Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Filters applied: . Clear all
Page 1
A double-blind, multicentre, placebo-controlled study of tiludronate in Paget's disease of bone.
Fraser WD, Stamp TC, Creek RA, Sawyer JP, Picot C. Fraser WD, et al. Among authors: stamp tc. Postgrad Med J. 1997 Aug;73(862):496-502. doi: 10.1136/pgmj.73.862.496. Postgrad Med J. 1997. PMID: 9307742 Free PMC article. Clinical Trial.
The response to oral tiludronate was sustained for more than 18 months in some patients and there was evidence of a reduction in the longer term complications of the disease. These results show that oral tiludronate is an effective, well-tolerated treatment for Paget's dis …
The response to oral tiludronate was sustained for more than 18 months in some patients and there was evidence of a reduction in the longer …
Fluoride therapy and parathyroid hormone activity in osteoporosis.
Stamp TC, Saphier PW, Loveridge N, Kelsey CR, Goldstein AJ, Katakity M, Jenkins MV, Rose GA. Stamp TC, et al. Clin Sci (Lond). 1990 Sep;79(3):233-8. doi: 10.1042/cs0790233. Clin Sci (Lond). 1990. PMID: 2169371 Clinical Trial.
To determine the relationships between parathyroid hormone activity and long-term sodium fluoride therapy in osteoporosis, cytochemical bioassays (for biologically active parathyroid hormone) were performed in 22 osteoporotic control patients and in 18 patients after 15 +/ …
To determine the relationships between parathyroid hormone activity and long-term sodium fluoride therapy in osteoporosis, cytochemic …
Fluoride therapy in osteoporosis: acute effects on parathyroid and mineral homoeostasis.
Stamp TC, Jenkins MV, Loveridge N, Saphier PW, Katakity M, MacArthur SE. Stamp TC, et al. Clin Sci (Lond). 1988 Aug;75(2):143-6. doi: 10.1042/cs0750143. Clin Sci (Lond). 1988. PMID: 3409631
By separate and opposing action(s) it inhibits intestinal calcium and phosphorus absorption, predominantly in those whose serum levels remain stable. All these effects may be relevant to long-term therapeutic results....
By separate and opposing action(s) it inhibits intestinal calcium and phosphorus absorption, predominantly in those whose serum levels remai …
Bone and joint symptoms in Paget's disease.
Winfield J, Stamp TC. Winfield J, et al. Among authors: stamp tc. Ann Rheum Dis. 1984 Dec;43(6):769-73. doi: 10.1136/ard.43.6.769. Ann Rheum Dis. 1984. PMID: 6240966 Free PMC article.
Fifty patients with Paget's disease of bone were reviewed with regard to the basis of their symptoms and the long-term results of treatment. Twenty-four patients (48%) presented with pain localised within bone, while 17 (34%) presented with symptoms of degenerative joint d …
Fifty patients with Paget's disease of bone were reviewed with regard to the basis of their symptoms and the long-term results of tre …
Urinary D-glucaric acid excretion during rifampicin/isoniazid and anticonvulsant enzyme induction.
Perry W, Stamp TC. Perry W, et al. Among authors: stamp tc. Clin Pharmacol Ther. 1984 May;35(5):710-5. doi: 10.1038/clpt.1984.99. Clin Pharmacol Ther. 1984. PMID: 6143635
Different active sites of rifampicin and isoniazid on glucuronic acid and other biochemical pathways emphasize the complexity of final metabolic effects in patients on long-term therapy....
Different active sites of rifampicin and isoniazid on glucuronic acid and other biochemical pathways emphasize the complexity of final metab …
Calcitriol dosage in osteomalacia, hypoparathyroidism and attempted treatment of myositis ossificans progressiva.
Stamp TC. Stamp TC. Curr Med Res Opin. 1981;7(5):316-36. doi: 10.1185/03007998109114276. Curr Med Res Opin. 1981. PMID: 6894416
By contrast, adult-presenting hypophosphataemic osteomalacia developed early hypercalcaemia on the same treatment; additional phosphate supplementation, without changing other treatment, abolished hypercalcaemia and improved calcium retention. A long-term crossover trial o …
By contrast, adult-presenting hypophosphataemic osteomalacia developed early hypercalcaemia on the same treatment; additional phosphate supp …
Comparison of oral 25-hydroxycholecalciferol, vitamin D, and ultraviolet light as determinants of circulating 25-hydroxyvitamin D.
Stamp TC, Haddad JG, Twigg CA. Stamp TC, et al. Lancet. 1977 Jun 25;1(8026):1341-3. doi: 10.1016/s0140-6736(77)92553-3. Lancet. 1977. PMID: 69059
Circulating concentrations of 25-hydroxyvitamin D (25-OHD) were measured during short-term and long-term oral treatment with 25-hydroxycholecalciferol (25-OHD3), 25-H.C.C.) or with vitamin D in over 200 subjects over a period of 5 years. ...
Circulating concentrations of 25-hydroxyvitamin D (25-OHD) were measured during short-term and long-term oral treatment with 2 …
11 results